News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
iEcure is developing the new drug candidate, GTP-506, as a treatment for a rare genetic condition caused by a genetic defect in a liver enzyme responsible for detoxification of ammonia.
Our PCI Fellows graduates are thriving in careers in IP law, mechanical engineering, life sciences investment, and more.
Philadelphia's innovation hub has seen explosive growth over the past several years, with significant expansions in manufacturing and research space for multiple companies.
In this Science Friday interview, Dr. Carl June discusses CAR-T's continued use in battling new blood cancers, as well as its future potential for treating solid state cancers and autoimmune diseases.
A new 90-second video animation created by the Chamber of Commerce for Greater Philadelphia’s CEO Council for Growth shows the Philadelphia region's gene and cell therapy family tree.
A proof-of-concept study has shown that these microrobots can also access the difficult-to-reach surfaces of the root canal with controlled precision.
PCI startup Vital Start Health empowers clinicians and caregivers by giving them a digital platform to improve neonatal care.
A team of researchers led by Dr. Deep Jariwala recently developed superlattices that offer controllable thickness, device-scale lateral size, and strong light absorption.
The annual B.PHL Innovation Festival serves as a gathering place for creatives, entrepreneurs, leaders, students, and industry change makers.
Tumors within the heart affect thousands of patients around the world annually, but prior to the ŌNŌ system, open-heart surgery was the only way to remove them.